Cargando…
Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056975/ https://www.ncbi.nlm.nih.gov/pubmed/27635734 http://dx.doi.org/10.1038/bcj.2016.85 |
| _version_ | 1782458973652254720 |
|---|---|
| author | Jethava, Y Mitchell, A Zangari, M Waheed, S Schinke, C Thanendrarajan, S Sawyer, J Alapat, D Tian, E Stein, C Khan, R Heuck, C J Petty, N Avery, D Steward, D Smith, R Bailey, C Epstein, J Yaccoby, S Hoering, A Crowley, J Morgan, G Barlogie, B van Rhee, F |
| author_facet | Jethava, Y Mitchell, A Zangari, M Waheed, S Schinke, C Thanendrarajan, S Sawyer, J Alapat, D Tian, E Stein, C Khan, R Heuck, C J Petty, N Avery, D Steward, D Smith, R Bailey, C Epstein, J Yaccoby, S Hoering, A Crowley, J Morgan, G Barlogie, B van Rhee, F |
| author_sort | Jethava, Y |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5056975 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50569752016-10-24 Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma Jethava, Y Mitchell, A Zangari, M Waheed, S Schinke, C Thanendrarajan, S Sawyer, J Alapat, D Tian, E Stein, C Khan, R Heuck, C J Petty, N Avery, D Steward, D Smith, R Bailey, C Epstein, J Yaccoby, S Hoering, A Crowley, J Morgan, G Barlogie, B van Rhee, F Blood Cancer J Corrigendum Nature Publishing Group 2016-09 2016-09-16 /pmc/articles/PMC5056975/ /pubmed/27635734 http://dx.doi.org/10.1038/bcj.2016.85 Text en Copyright © 2016 Macmillan Publishers Limited |
| spellingShingle | Corrigendum Jethava, Y Mitchell, A Zangari, M Waheed, S Schinke, C Thanendrarajan, S Sawyer, J Alapat, D Tian, E Stein, C Khan, R Heuck, C J Petty, N Avery, D Steward, D Smith, R Bailey, C Epstein, J Yaccoby, S Hoering, A Crowley, J Morgan, G Barlogie, B van Rhee, F Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma |
| title | Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma |
| title_full | Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma |
| title_fullStr | Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma |
| title_full_unstemmed | Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma |
| title_short | Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma |
| title_sort | dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056975/ https://www.ncbi.nlm.nih.gov/pubmed/27635734 http://dx.doi.org/10.1038/bcj.2016.85 |
| work_keys_str_mv | AT jethavay dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT mitchella dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT zangarim dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT waheeds dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT schinkec dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT thanendrarajans dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT sawyerj dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT alapatd dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT tiane dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT steinc dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT khanr dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT heuckcj dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT pettyn dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT averyd dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT stewardd dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT smithr dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT baileyc dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT epsteinj dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT yaccobys dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT hoeringa dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT crowleyj dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT morgang dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT barlogieb dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma AT vanrheef dosedenseandlessdoseintensetotaltherapy5forgeneexpressionprofilingdefinedhighriskmultiplemyeloma |